5.2
Impact Factor
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Corrigendum
Current Issue
Editorial
Erratum
Full Length Article
Full lenth article
Letter to Editor
Original Article
Research article
Retraction
Retraction notice
Review
Review Article
SPECIAL ISSUE: ENVIRONMENTAL CHEMISTRY
5.3
Impact Factor
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Corrigendum
Current Issue
Editorial
Erratum
Full Length Article
Full lenth article
Letter to Editor
Original Article
Research article
Retraction
Retraction notice
Review
Review Article
SPECIAL ISSUE: ENVIRONMENTAL CHEMISTRY
View/Download PDF

Translate this page into:

Original article
10 (
5
); 732-738
doi:
10.1016/j.arabjc.2014.07.002

Evaluation of invitro α-amylase and α-glucosidase inhibitory potential of N2O2 schiff base Zn complex

Laboratory of Bioprocess and Engineering, Department of Biochemistry, Periyar University, Salem 636 011, Tamil Nadu, India
Department of Chemistry, Periyar University, Salem 636 011, Tamil Nadu, India
Department of Nutrition and Dietetics, Faculty of Allied Health Sciences, Chulalongkorn University, Bangkok 10330, Thailand

⁎Corresponding author. Tel.: +91 427 2345766/520; fax: +91 427 2345124. pal2912@yahoo.com (Thayumanavan Palvannan)

Disclaimer:
This article was originally published by Elsevier and was migrated to Scientific Scholar after the change of Publisher.

Peer review under responsibility of King Saud University.

Abstract

The evaluation of the antioxidant, antibacterial and enzyme inhibition effects of N2O2 Schiff base Zn complex was investigated. The percentage scavenging activity of hydroxyl radical (IC50-0.21 μg), ABTS (IC50-0.19 μg) and DPPH (IC50-0.25 μg) shows that ZnL complex had a potential antioxidant activity. The antibacterial activity of ZnL complex was evaluated. Results showed that MIC value against Staphylococcus aureus and Salmonella typhi was 100 and 200 μg/ml, respectively. ZnL complex showed strong inhibition toward α-amylase and α-glucosidase with an IC50 value of 0.18 and 0.23 μg, respectively. The inhibition mechanism was analyzed with LB and Dixon plots. The ZnL complex could be a mixed noncompetitive and noncompetitive inhibitor with Ki values of 77.8 and 31.6 μg for α-amylase and α-glucosidase, respectively. The preliminary assessment of ZnL complex showed that they can be used as an antioxidant, antibacterial and antidiabetic agents.

Keywords

ZnL complex
Antioxidant
Antibacterial
Kinetic studies

Abbreviations

ABTS

2,2′-azinobis-3-ethylbenzothiazoline-6-sulfonic acid

DNS

dinitro salicylic acid

DPPH

1-1-diphenyl 2-picryl hydrazyl

IC50

half maximal inhibitory concentration

LB

Lineweaver–Burk

MIC

minimum inhibitory concentration

S. aureus

Staphylococcus aureus

S. typhi

Salmonella typhi

ZnL complex

N2O2 Schiff base Zn complex

1

1 Introduction

Metal complexes play an essential role in agriculture, pharmaceutical and industrial chemistry. Ligand, a metal surrounded by a cluster of ions or molecule, is used for the preparation of complex compounds named as Schiff bases, which are condensation products of primary amines and aldehydes or ketones (RCH = NR′, where R & R′ represent alkyl and/or aryl substituents) (Dhar and Taploo, 1982). Many Schiff bases are known to be medicinally important and used to design medicinal compounds (Khan et al., 2008; Iqbal et al., 2009). It was seen that the biological activity of Schiff bases either increases or decreases upon chelation with metal ions (Kulkarni et al., 2009; Puthilibai et al., 2009; Avaji et al., 2009). Schiff bases and their metal complexes show antibacterial activities against Escherichia coli, Staphylococcus aureus, Streptococcus pyogenes, Pseudomonas aeruginosa and Salmonella typhi and antifungal activities against Aspergillus niger, Aspergillus flavus and Cladosporium (Bagihalli et al., 2008). Free radicals, produced as a result of normal biochemical reactions in the body, are implicated in contributing to cancer, atherosclerosis, aging, immunosuppression, inflammation, ischemic heart disease, diabetes, hair loss, and neurodegenerative disorders such as Alzheimer’s disease and Parkinson’s disease (Beal, 1995; Maxwell, 1995; Poulson et al., 1998).

Diabetes mellitus is a clinical syndrome with severe socioeconomic importance characterized by hyperglycemias due to absolute or relative lack of insulin (Aguwa, 2004). One of the strategies adopted to treat diabetes mellitus involves inhibition of carbohydrate-digesting enzymes such as α-amylase and α-glucosidase in the gastrointestinal tract, with associated retardation of intestinal glucose absorption and lowering of postprandial blood glucose levels (Rhabasa-Lhoret and Chiasson, 2004). α-Glucosidase cleaves glycosidic bonds in complex carbohydrate to release absorbable monosaccharides. Inhibitors of α-glucosidase display useful anti-hyperglycemic effects (Stuart et al., 2004). In the present study determination of antioxidant and antibacterial activities of ZnL complex and evaluation of ZnL complex in the inhibition of α-amylase and α-glucosidase, were carried out. Enzyme kinetic studies were also performed to understand the possible mode of inhibition of ZnL complex.

2

2 Materials and methods

2.1

2.1 Chemicals

ABTS (2,2′-azinobis-3-ethylbenzothiazoline-6-sulfonic acid), DPPH, p-nitrophenyl-a-d-glucopyranoside, α-amylase and α-glucosidase were purchased from Sigma–Aldrich Chemical Corporation, St. Louis, Mo, USA. DNS (dinitro salicylic acid) was obtained from Himedia chemicals, India, and all other chemicals were of analytical grade.

2.2

2.2 Synthesis and characterization of bis(3-acetyl-5-methyl-pyran-2,4-dione)ethylenediimine Zn(II) complex complex (ZnL)

The Schiff base ligand, bis(3-Acetyl-5-methyl-pyran-2,4-dione)ethylenediimine (H2L) and its Zinc complex (ZnL) were synthesized according to the procedure of Ponnam deshmukg et al., 2010 with slight modification. H2L was prepared from the condensation of dehydroacetic acid and ethylene diamine in ethanol medium at 70 °C. The Zn(II) Schiff base complex (ZnL) was synthesized from the ligand (Fig. 1). Color: Pale yellow; Yield: 62%; Melting point: 163 °C.

Structure of N2O2 Schiff base Zn complex.
Figure 1 Structure of N2O2 Schiff base Zn complex.

In the next step, the ligand (1.1232 g, 4 mmol) was dissolved in ethanol (20 ml) by heating at 80 °C. The obtained solution was mixed with ethanol containing zinc chloride dehydrate drop by drop with continuous stirring and the resulting reaction mixture was further refluxed for 5 h. On cooling the reaction mixture, a solid product gets settled. The product was filtered, washed with absolute ethanol followed by petroleum ether and dried in vacuum. Color: Brown; Yield: 74%; Melting point: 226 °C.

2.3

2.3 Antioxidant activity

2.3.1

2.3.1 Determination of hydroxyl radical scavenging activity

The hydroxyl radical scavenging activity of ZnL complex was determined according to the method of Smirnoff and Cumbes (1989). Different concentrations of ZnL complex (100–500 μg/ml), were added to 1 mM FeCl3, 1 mM EDTA, 20 mM H2O2, 1 mM L-ascorbic acid and 30 mM deoxyribose in potassium phosphate buffer (pH 7.4) and were incubated for 1 h at 37 °C. In addition of 1 ml of 2.8% (w/v) trichloroacetic acid and 1 ml of 1% (w/w) 2-thiobarbituric acid the solution mixture was heated in a boiling water-bath for 15 min and the absorbance was measured at 532 nm. Ascorbic acid was used as a positive control.

2.3.2

2.3.2 DPPH (1-1-diphenyl 2-picryl hydrazyl)

The DPPH scavenging activity was determined by an assay modified method of Kwon et al. (2006). Solution of DPPH in ethanol (0.1 mM) was prepared and 1.0 ml of this solution was added to 2 ml of ZnL complex solution at different concentrations (100–500 μg/ml) and the reaction mixture was vortexed for 10 s and allowed to stand at room temperature for 30 min. The absorbance was recorded at 517 nm by using a UV–Vis spectrophotometer. The percentage of DPPH radical scavenging activity was expressed as [1 − (Test sample absorbance/Blank sample absorbance)] × 100 (%). Ascorbic acid was used as reference antioxidant compound.

2.3.3

2.3.3 ABTS (2,2′-azinobis-3-ethylbenzothiazoline-6-sulfonic acid)

The ABTS radical scavenging assay was carried out according to the method given by Arnao et al. (2003). The ABTS radical solution was prepared freshly by adding 5 ml of 4.9 mM ammonium persulfate solution to 5 ml of a 14 mM ABTS solution and kept for 16 h under dark condition. The solution was diluted with distilled water to yield an absorbance of 0.70 ± 0.02 at 734 nm and the same was used for the assay. Different concentrations of ZnL complex (100–500 μg/ml) were prepared. A total of 900 μl of ABTS radical solution, was added to 100 μl of the ZnL complex and the reaction mixture was vortexed for 10 Sec. Absorbance at 734 nm was noted after six min against the blank by using a UV–Vis spectrophotometer. The test solution was compared with the control ABTS solution and expressed as ABTS+ scavenging activity in percentage as 1 − (Test sample absorbance/Blank sample absorbance) × 100 (%). Ascorbic acid was used as reference compound.

2.4

2.4 Antibacterial analysis

Antibacterial activity was performed according to the method of Threlfall et al. (1999) and Walker et al. (2000) using 10 g peptone, 10 g NaCl and 5 g yeast, 20 g agar in 1000 ml of distilled water. The stock cultures of bacteria were revived by inoculating in broth media and grown at 37 °C for 18 h. Agar plates were prepared and wells were made in the plate. Each plate was inoculated with 18 h old cultures (100 μl, 10−4 cfu) and spread evenly on the plate. After 20 min, the wells were filled with compound of different concentrations. The control wells with gentamicin were also prepared. The plates were incubated at 37 °C for 24 h and all the tests were performed in triplicate and the average was taken as final reading. The inhibition zone diameters were measured in millimeters.

2.5

2.5 α-Amylase inhibition assay

α-Amylase inhibitory activity was determined by the method described by the Worthington Enzyme Manual (Worthington Biochemical Corp., 1993a) with slight modification. A total of 500 μl of ZnL complex and 500 μl of 0.02 M sodium phosphate buffer (pH 6.9 with 0.006 M NaCl) containing α-amylase solution (1.0 U/ml) was incubated at 25 °C for 10 min. After pre incubation, 500 μl of 1% starch solution was added to 0.02 M sodium phosphate buffer (pH 6.9 with 0.006 M NaCl). The reaction mixture was then incubated at 25 °C for 10 min. The reaction was stopped by adding 1.0 ml of DNS color reagent. The test tubes were then incubated in a boiling water bath for 5 min and cooled to room temperature. The reaction mixture was then diluted by adding 10 ml of distilled water, and absorbance was measured at 540 nm. The α-amylase inhibitory activity was calculated according to the equation given below: Inhibition ( % ) = ( A control - A sample ) / A control × 100 where Acontrol was the absorbance of the control (without ZnL complex); Asample was the absorbance in the presence of ZnL complex.

2.6

2.6 α-Glucosidase inhibition assay

A modified version of the assay described by the Worthington Enzyme Manual was followed (Worthington Biochemical Corp., 1993b). A volume of 500 μl of ZnL complex was diluted with 100 μl of 0.1 M potassium phosphate buffer (pH 6.9) containing α-glucosidase solution (1.0 U/ml) and was incubated in 96-well plates at 25 °C for 10 min. After pre incubation, 50 μl of 5 mM p-nitrophenyl-α-D-glucopyranoside solution in 0.1 M potassium phosphate buffer (pH 6.9) was added to each well at timed intervals. The reaction mixtures were incubated at 25 °C for 5 min. The α-glucosidase inhibitory activity was expressed as percentage of inhibition and was calculated as follows: Inhibition ( % ) = ( A control - A sample ) / A control × 100 where Acontrol was the absorbance of the control (without ZnL complex); Asample was the absorbance in the presence of ZnL complex.

2.7

2.7 Kinetics of inhibition

The mode of inhibition of α-amylase and α-glucosidase by ZnL complex was determined by using Dixon and Lineweaver–Burk plots. Starch in the concentration range 0.5–2%, and p-nitrophenyl-α-d-glucopyranoside in the range 0.5–2 mM, were used as substrates for α-amylase and α-glucosidase respectively. The inhibitions of enzyme activities are determined in the presence and absence of ZnL complex at different concentrations for α-amylase (50–200 μg/ml) and α-glucosidase (20–80 μg/ml). The values of kinetic parameters (Km and Ki) were determined according to the type of inhibition for each enzyme reaction with ZnL complex by both LB and Dixon plots (Bowden, 1974; Dixon, 1953).

2.8

2.8 Statistical analysis

Analysis at every time point from each experiment was carried out in triplicates. The results were statistically analyzed by ANOVA. Statistical significance was accepted at a level of p < 0.05.

3

3 Results and discussion

3.1

3.1 Synthesis and characterization

IR spectrum of ligand (H2L) exhibits characteristic peaks at 3282, 2818, 1638, and 1616 cm−1 which correspond to phenolic (–O–H) stretching, C–H stretching, carbonyl (C⚌O) stretching and azomethine (C⚌N) stretching vibration frequencies, respectively. Phenolic (O-H) stretching disappeared in the IR spectrum of complexes which indicates the binding of ligand with ‘Zn’ ion via deprotonation. The IR spectrum of ZnL exhibits C⚌O stretching at 1633 cm−1, almost similar to that of ligand spectrum. This shows that the carbonyl group remains free and does not involve in any new bonding. Whereas the azomethine frequency undergoes a red shift (1607 cm−1) in complexes. This clearly shows the binding of azomethine nitrogen with Zn ion. Thus, the IR spectra of H2L and ZnL clearly exhibit the binding of ligand with metal through two azomethine nitrogens and two phenolic oxygens. UV–Vis spectrum was recorded for the complex ZnL, which exhibits three peaks at wavelengths (λmax) 224, 286 and 424 nm. Bands at 224 and 286 nm were attributed to intra ligand electronic transitions. Peaks at 424 nm can be due to M-L charge transfer.

1H-NMR spectra of H2L and ZnL further confirm the binding of ligand with Zn ion. Phenolic OH proton exhibits a peak at the chemical shift of 11.4 ppm. This peak disappear in the 1HNMR spectra of ZnL confirms the deprotonation due to the binding of phenolic oxygen with the metal group. The peaks corresponding to free methyl groups have been observed at similar region (2.1–2.5 ppm) in both the spectrum of ligand and complex. Methylene (–CH2–) protons and ring (C–H) protons exhibit their peaks around 2.8 and 3.6 ppm, receptively. The spectral results confirm that H2L acts as a binegative quadridentate ligand in nature.

3.2

3.2 Hydroxyl radical scavenging activity

In the present study the ZnL complex exhibited a significant strongest hydroxyl radical scavenging activity as compared with ascorbic acid Fig. 2. IC50 values of ZnL complex and ascorbic acid were found to be 0.21 and 0.18 μg/ml, respectively (Table 1). This result shows that ZnL complex exhibited a dose dependent antioxidant activity. The free radicals such as hydroxyl and superoxide radical are formed in biological systems and they have been associated as an extremely damaging species in free radical pathology, capable of injurious to almost every molecule found in living cells (Gulcin, 2006). Hydroxyl radicals are very strongly reactive oxygen species and there is no specific enzyme to defend against them in humans (Liu et al., 2005).

Hydroxyl radical scavenging activity of the ZnL complex. Mean inhibition (%) ± SDn significantly different (p < 0.05), n = values are given as mean of three replicates.
Figure 2 Hydroxyl radical scavenging activity of the ZnL complex. Mean inhibition (%) ± SDn significantly different (p < 0.05), n = values are given as mean of three replicates.
Table 1 Effect of ZnL complex half maximal inhibitory concentration (IC50) on different antioxidant activities.
Types of assay Ascorbic acid (μg/ml) IC50 N2O2 Schiff base ZnL complex (μg/ml) IC50
FRAP 0.18 0.21
ABTS 0.1 0.19
DPPH 0.22 0.25

3.3

3.3 Inhibition of DPPH radical scavenging activity (1-1-diphenyl 2-picryl hydrazyl)

The highest DPPH scavenging activity was found in ZnL complex. The scavenging activity of ZnL complex was compared with that of ascorbic acid. The results showed that, ZnL complex had significant scavenging effects with increasing concentration in the range of 100–500 μg/ml. When compared to ascorbic acid; the scavenging effect of ZnL complex was lower. The IC50 values were found to be 0.25 and 0.22 μg/ml for ZnL complex and ascorbic acid, respectively (Table 1). DPPH scavenging activity of the ZnL complex is a dose dependent in vitro antioxidant activity. The method was based on the reduction of alcoholic DPPH solution in the presence of a hydrogen-donating antioxidant due to the formation of the non-radical DPPH (Soares et al., 1997). Fig. 3 displays the DPPH activity of ZnL complex in percentage of free radical scavenging activity. The higher DPPH radical-scavenging activity is associated with the lower IC50 value. The DPPH was determined by the decrease in its absorbance at 517 nm. The DPPH scavenging method has been used to evaluate the antioxidant activity of compounds due to its simplicity, rapidity, sensitivity and reproducibility (Ozcelik et al., 2003). The absorbance decreased when the DPPH is scavenged by an antioxidant through donation of hydrogen to form a stable DPPH radical molecule. In the radical form, this molecule has an absorbance at 517 nm, which disappears after acceptance of an electron or hydrogen radical from an antioxidant compound to become a stable diamagnetic molecule (Matthaus, 2002). When DPPH reacts with suitable reducing agents, the electrons become paired off and the solutions lose color stoichiometrically depending upon the incoming electron (Rock et al., 1996; Sies and Stahl 1995).

The DPPH radical scavenging activity of ZnL complex. Mean inhibition (%) ± SDn significantly different (p < 0.05), n = values are given as mean of three replicates.
Figure 3 The DPPH radical scavenging activity of ZnL complex. Mean inhibition (%) ± SDn significantly different (p < 0.05), n = values are given as mean of three replicates.

3.4

3.4 ABTS (2,2′-azinobis-3-ethylbenzothiazoline-6-sulfonic acid) radical scavenging assay

ABTS radical-scavenging is a common method used to assess the antioxidant activity of the ZnL complex compared to that of ascorbic acid. In the present study the reduction of ABTS by ZnL complex was determined and the reducing capacity of ZnL complex was noted. ZnL complex and ascorbic acid scavenged the ABTS radicals at a concentration of 100–500 μg/ml. IC50 value of ZnL complex and ascorbic acid was 0.1 and 0.19 μg/ml, respectively. The result is shown in Table 1. As shown in Fig. 4, the ZnL complex displayed potential scavenging effect of ABTS radicals. ABTS radical cation decolorization technique was a widely accepted method/assay (Greene et al., 1987). ABTS radical is a blue chromophore produced by the reaction of ABTS and potassium persulfate after incubation in the dark environment. The reaction of ZnL complex with this preformed radical cation decolorized the blue chromophore with increasing concentration (Igbinosa et al., 2011).

The ABTS scavenging activity of ZnL complex. Mean inhibition (%) ± SDn Significantly different (p < 0.05), n = values are given as mean of three replicates.
Figure 4 The ABTS scavenging activity of ZnL complex. Mean inhibition (%) ± SDn Significantly different (p < 0.05), n = values are given as mean of three replicates.

3.5

3.5 Antibacterial activity

ZnL complex was screened for their antibacterial activity against S. aureus and S. typhi. Table 2 shows the antibacterial activity of ZnL complex. The results showed that ZnL complex exhibited a potential antibacterial activity against the standard drug gentamicin (S. aureus and S. typhi), respectively (Table 2).The ZnL complex exhibited significant activity and the zone of inhibition was up to 24–28 and 21–24 mm at a concentration of 800 μg/ml against S. aureus and S. typhi respectively. Schiff base derived from furylglyoxal and p-toluidene showed antibacterial activity against E. coli, S. aureus, Bacillus subtilis and Proteus vulgaris. Metal complexes of Mo(IV) and Mn(II) with ligands hydrazine carboxamide and hydrazine carbothiamide showed antibacterial activity against S. aureus and Xanthomonas compestris (Bhardwaj and Singh 1994). Bharti et al. (2010) reported that 2,4-disubstituted thiazole ring which was carrying imino-1,2 diphenylethanol substituent appeared to exhibit the highest anti-bacterial activity against S. aureus and Vibrio cholera with the MIC of 12.5 and 25 μg/ml. The 6,8-dibromo-4(3H) quinazolinone derivatives were screened for their antibacterial activity against S. aureus and it exhibited the MIC of 25 μg/ml (Mosaad Mohamed et al., 2010).

Table 2 Anti bacterial activity of ZnL complex.
Concentration (μg/ml) Tested strains (mm)
S. aureus S. typhi S. aureus S. typhi
N2O2 Schiff base ZnL complex Gentamicin mm
25 −ve −ve 13–15 2–4
50 −ve −ve 18–20 13–15
100 5–8 −ve 21–23 16–19
200 10–12 7–10 25–28 21–24
400 16–19 15–17 27–30 25–28
800 24–28 21–24 34–36 27–30
MIC value 100 200 <25 25

MIC (μg/ml)-minimum inhibitory concentration. The zone of inhibition was measured in mm and gentamicin was used as standard drug for anti-bacterial activity.

3.6

3.6 Inhibition of α-amylase and α-glucosidase activity

The α-amylase and α-glucosidase inhibitory properties of the ZnL complex are presented in Figs. 5 and 6. The ZnL complex inhibited both α-amylase and α-glucosidase in a dose dependent manner. The IC50 values for α-amylase and α-glucosidase were found to be 0.18 and 0.23 mg ZnL complex, respectively (Table 3). Inhibition of enzymes involved in the hydrolysis of carbohydrates such as α-amylase and α-glucosidase has been exploited as a therapeutic approach for controlling postprandial hyperglycemia (Shim et al., 2003). The inhibition activity of α-amylase was extended and might be responsible for decreasing the rate of glucose absorption and concentration of postprandial serum glucose (Chau et al., 2003; Kwon et al., 2007). This effect would delay the degradation of starch and oligosaccharides, which would in turn cause a decrease in the absorption of glucose and consequently inhibit the increase in postprandial blood glucose (Lee et al., 2007). In the human species, α-amylase is present in both salivary and pancreatic secretions. This enzyme is responsible for cleaving large malto-oligosaccharides to maltose, which is then a substrate for intestinal α-glucosidase (Ramasubbu et al., 2004).

Inhibition of α-amylase activities by ZnL complex.
Figure 5 Inhibition of α-amylase activities by ZnL complex.
Inhibition of α-glucosidase activities by ZnL complex.
Figure 6 Inhibition of α-glucosidase activities by ZnL complex.
Table 3 Mode of inhibition and kinetic properties of ZnL complex on α-amylase and α-glucosidase.
Parameter α-Amylase α-Glucosidase
Km 0.35 1.4
Ki (μg) 77.8 31.6
Mode on inhibition Mixed noncompetitive Noncompetitive
IC50 (mg) 0.18 0.23

3.7

3.7 Mode of inhibition

ZnL complex is likely to influence the α-amylase and α-glucosidase in quite a number of ways, for instance it competes with the substrate to bind the active site of the enzyme or it disrupts the catalytic process irreversibly. Kinetic studies were carried out to identify the mode of inhibition of ZnL complex using the LB plot. Fig. 7A and B shows the straight lines intercepting at a single point in the second quadrant indicating mixed noncompetitive and noncompetitive inhibition for α-amylase and α-glucosidase with inhibitory constant (Ki) value of ZnL complex of 77.8 and 31.6 μg, respectively (Fig. 8A and B). Kinetic constants (Ki) for the inhibition of α-glucosidase and α-amylase are listed in Table 3. Apostolidis et al. (2007) reported that kinetic inhibition of porcine pancreatic α-amylase by acarbose, maltose and maltotriose was mixed non-competitive type inhibition.

LB plot analysis of the inhibition kinetics of (A) α-amylase and (B) α-glucosidase effects by ZnL complex.
Figure 7 LB plot analysis of the inhibition kinetics of (A) α-amylase and (B) α-glucosidase effects by ZnL complex.
Dixon plot analysis of kinetic constants of (A) α-amylase and (B) α-glucosidase effects by ZnL complex.
Figure 8 Dixon plot analysis of kinetic constants of (A) α-amylase and (B) α-glucosidase effects by ZnL complex.

4

4 Conclusion

In the present investigation, ZnL complex showed good antioxidant activity. Antibacterial activity of ZnL complex was evaluated against microorganisms S. aureus and S. typhi. Antibacterial activity of ZnL complex was noticed to be higher in case of S. aureus than in S. typhi. In vitro studies displayed that the complex showed a potential inhibitory activity of α-amylase and α-glucosidase. The in vitro analysis provides an insight of enzyme inhibitory activity of ZnL complex. The ZnL complex is found to be an effective mixed non competitive and non competitive inhibitor of α-amylase and α-glucosidase respectively. These findings provided scientific evidence to support ZnL complex as a potential candidate to be used as an antioxidant, antibacterial and antidiabetic drugs.

References

  1. , . Therapeutic Basis for Clinical Pharmacy in the Tropics (3rd ed.). Enugu: SNAAP Press Ltd.; . pp. 125–230
  2. , , , . Inhibitory potential of herb, fruit, and fungal enriched cheese against key enzymes linked to type 2 diabetes and hypertension. Innov. Food Sci. Emerg. Technol.. 2007;8:46-54.
    [Google Scholar]
  3. , , , . The hydrophilic and lipophilic contribution to total antioxidant activity. Food Chem.. 2003;73:239-244.
    [Google Scholar]
  4. , , , , , . Synthesis, spectral characterization, in-vitro micobiological evaluation and cytotoxic activities of novel macrocyclic bishydrazone. Eur. J. Med. Chem.. 2009;44:3552-3559.
    [Google Scholar]
  5. , , , , . Synthesis, spectral characterization, in vitro antibacterial, antifungal and cytotoxic activities of Co(II), Ni(II) and Cu(II) complexes with 1,2,4-triazole Schiff bases. Eur. J. Med. Chem.. 2008;43:2639-2649.
    [Google Scholar]
  6. , . Aging, energy and oxidative stress in neurodegenerative diseases. Ann. Neurol.. 1995;38:357-366.
    [Google Scholar]
  7. , , . Synthesis and characterization of thallium(I) complexes of biologically active benzothiazolines. Indian J. Chem.. 1994;33A:423-425.
    [Google Scholar]
  8. , , , , . Synthesis, anti-bacterial and anti-fungal activities of some novel Schiff bases containing 2,4-disubstituted thiazole ring. Eur. J. Med. Chem.. 2010;45:651-660.
    [Google Scholar]
  9. , . A simple method for determining the inhibition constants of mixed, uncompetitive and non-competitive inhibitors. Biochem. J.. 1974;137:143-144.
    [Google Scholar]
  10. , , , . In vitro hypoglycemic effects of different insoluble fiber-rich fractions prepared from the peel of Citrus sinensis L. cv. Liucheng. J. Agric. Food Chem.. 2003;51:6623-6626.
    [Google Scholar]
  11. , , . Schiff bases and their applications. J. Sci. Ind. Res.. 1982;41:501-506.
    [Google Scholar]
  12. , . The determination of enzyme inhibitor constants. Biochem. J.. 1953;55:170-171.
    [Google Scholar]
  13. , , , , . PC12 pheochromocytoma cells: culture, nerve growth factor treatment, and experimental exploitation. Methods Enzymol.. 1987;147:207-216.
    [Google Scholar]
  14. , . Antioxidant and antiradical activities of L-carnitine. Life Sci.. 2006;78:803-811.
    [Google Scholar]
  15. , , , , , , . Polyphenolic contents and antioxidant potential of stem bark extracts from Jatropha curcas (Linn) Int. J. Mol. Sci.. 2011;12:2958-2971.
    [Google Scholar]
  16. , , , , . Effect of derivatization of sulfamethoxazole and trimethoprim with copper and zinc on their medicinal value. Med. Chem. Res.. 2009;18:31-42.
    [Google Scholar]
  17. , , , . Bactericidal activity of 2-nitroimidazole against activereplicating stage of Mycobacterium bovis BCG and M. tuberculosis with intracellular efficacy in THP-1 macrophage. Int. J. Antimicrob. Agents. 2008;32:40-45.
    [Google Scholar]
  18. , , , , , . Synthesis, spectral, electrochemical and biological studies of Co(II), Ni(II) and Cu(II) complexes with Schiff bases of 8-formyl-7-hydroxy-4-methyl coumarin. J. Coord. Chem.. 2009;62:481-492.
    [Google Scholar]
  19. , , , , . Health benefits of traditional corn, beans and pumpkin: in vitro studies for hyperglycemia and hypertension management. J. Med. Food.. 2007;10:266-275.
    [Google Scholar]
  20. , , , , . Inhibitory activities of proanthocyanidins from persimmon against oxidative stress and digestive enzymes related to diabetes. J. Nutr. Sci. Vitaminol.. 2007;53:287-292.
    [Google Scholar]
  21. , , , , , . On changes of activity of antioxidases in hippocampus of rats with multi-infarct dementia and the intervention effects of acupuncture. China J. Tradit. Chin. Med. Pharm.. 2005;20:724-726.
    [Google Scholar]
  22. , . Antioxidant activity of extracts obtained from residues of different oilseeds. J. Agric. Food Chem.. 2002;50:3444-3452.
    [Google Scholar]
  23. , . Prospects for the use of antioxidant therapies. Drugs. 1995;45:345-361.
    [Google Scholar]
  24. , , , , , , . Novel 6,8-dibromo-4(3H) quinazolinone derivatives of anti-bacterial and anti-fungal activities. Eur. J. Med. Chem.. 2010;45:3311-3319.
    [Google Scholar]
  25. , , , . Effects of light, oxygen and pH on the 2,2-diphenyl-1 picrylhydrazyl (DPPH) method to evaluate antioxidants. J. Food Sci.. 2003;68:487-490.
    [Google Scholar]
  26. , , , , . Synthesis, characterization and thermogravimetric studies of some metal complexes with N2O2 schiff base ligand. World J. Chem.. 2010;5:57-61.
    [Google Scholar]
  27. , , , . Role of oxidative DNA damage in cancer initiation and promotion. Eur. J. Cancer Prev.. 1998;7:9-16.
    [Google Scholar]
  28. , , , , . Synthesis, spectroscopic characterization, electrochemical behaviour and antibacterial activity of Ru(III) complexes of 2-[(4-N,N′-dimethylaminophenylimino)-methyl]-4-halophenol. Spectrochim. Acta, Part A. 2009;72:796-800.
    [Google Scholar]
  29. , , , , , , . Human salivary alpha-amylase Trp58 situated at subsite-2 is critical for enzyme activity. Eur. J. Med. Chem.. 2004;271:2517-2529.
    [Google Scholar]
  30. , , . Alpha-glucosidase inhibitors. In: , , , , eds. International Textbook of Diabetes Mellitus. In: , , , , eds. 3rd Ed.. Vol vol. 1. UK: John Wiley; .
    [Google Scholar]
  31. , , , . Update on the biological characteristics of the antioxidant micronutrients: vitamin C, vitamin E, and the carotenoids. J. Am. Diet Assoc.. 1996;96:693-702.
    [Google Scholar]
  32. , , , , , , . Inhibitory effect of aqueous extract from the gal of Rhuz chinesis on alpha-glucosidase activities and postprandial blood glucose. J. Ethnopharmacol.. 2003;85:283-287.
    [Google Scholar]
  33. , , . Vitamins E and C, β-carotene, and other carotenoids as antioxidants. Am. J. Clin. Nutr.. 1995;62 5S-1321S
    [Google Scholar]
  34. , , . Hydroxyl radical scavenging activity of compatible solutes. Phytochem. 1989;28:1057-1060.
    [Google Scholar]
  35. , , , , . Antioxidant activities of some extracts of Thymus zygis. Free Radic. Res.. 1997;26:469-478.
    [Google Scholar]
  36. , , , . Chemistry and biochemistry of type 2 diabetes. Chem. Rev.. 2004;104:1255-1282.
    [Google Scholar]
  37. , , , , , . Harmonization of antibiotic susceptibility testing for Salmonella: Results of a study by 18 national reference laboratories within the European Union-funded Enter-Net group. Microb. Drug Resist.. 1999;5:195-199.
    [Google Scholar]
  38. , , , , . Antimicrobial susceptibility testing and interpretation of results. In: Antimicrobial Therapy in Veterinary Medicine. Ames, IA: Iowa State University Press; . p. :12-26.
    [Google Scholar]
  39. Worthington Biochemical Corp., 1993a. Alpha amylase. In: V. Worthington (Eds.), Worthington Enzyme Manual. Freehold, pp. 36–41.
  40. Worthington Biochemical Corp., 1993b. Maltase-α-glucosidase. In: V. Worthington (Eds.), Worthington Enzyme Manual. Freehold, p. 261.
Show Sections